2 10 3 cells (PC-3, DU-145, LNCaP, 22Rv1, BPH) were seeded into 96-well plates and treated with ALCAR (range: 50 M, 100 M, 200 M, 500 M, 1 mM, 5 mM or 10 mM) for 24, 48 and 72 h
Gastrointestinal adverse reactions with CARNITOR (levocarnitine) Oral Solution or CARNITOR SF (levocarnitine) Sugar-Free Oral Solution dissolved in liquids might be avoided by a slow consumption of the solution or by a greater dilution
The barrier tightness of the model was verified by transendothelial electrical resistance (TEER) measurements using an EVOM voltohmmeter (World Precision Instruments, USA) combined with STX-2 electrodes
[DOI] [PMC free article] [PubMed] [Google Scholar] Peng G, Dixon DA, Muga SJ, Smith TJ, Wargovich MJ
All prescriptions are reviewed and approved by licensed physicians to ensure proper dosage and suitability
Register for access to our free webcast: ...or contact us: #pharma #deviceregulatory #riskmanagement #combinationproduct #drugdelivery #FDA #regulatoryaffairs Max Lerman, PhD Sarah Mollo Rob Schulz BlueRidge Life Sciences To view or add a comment, sign in The FDA has taken a step toward greater transparency and efficiency in drug development by publishing the internal filing checklists used by CDER reviewers